Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CARsgen Therapeutics HoldingsCRTHF 21 Days Inventory is 68.26 as of Dec. 2025, which is 22% above its 10-year median of 55.81. GuruFocus rates CRTHF with a GF Score™ of 21/100. The stock has 3 warning signs investors should review. Among 638 Biotechnology companies, CARsgen Therapeutics Holdings ranks better than 81.5% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
CARsgen Therapeutics Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.67.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CARsgen Therapeutics Holdings's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.12.
CARsgen Therapeutics Holdings (OTCPK:CRTHF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
CARsgen Therapeutics Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CARsgen Therapeutics Holdings's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
CARsgen Therapeutics Holdings Days Inventory Related Terms
CARsgen Therapeutics Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CARsgen Therapeutics Holdings Days Inventory Chart
CRTHF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, CARsgen Therapeutics Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CARsgen Therapeutics Holdings Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CARsgen Therapeutics Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where CARsgen Therapeutics Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CARsgen Therapeutics Holdings (CRTHF) has a Days Inventory of 68.26 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on CARsgen Therapeutics Holdings and its competitors. This is 22% above median its historical median of 55.81. Over the past decade, CARsgen Therapeutics Holdings' Days Inventory has ranged from 55.22 to 66.43. According to the industry distribution chart, CARsgen Therapeutics Holdings ranks #118 out of 638 companies in the Biotechnology industry, placing it in the top 18.5%.
Is CARsgen Therapeutics Holdings' Days Inventory too high?
CARsgen Therapeutics Holdings' current Days Inventory of 68.26 is 22% above median its 10-year median of 55.81. Over the past 10 years, this metric has ranged from a low of 55.22 to a high of 66.43. The Biotechnology industry median Days Inventory is 183.20. CARsgen Therapeutics Holdings' value of 68.26 is 62.7% below this industry median. Based on the distribution chart, CARsgen Therapeutics Holdings ranks #118 out of 638 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, CARsgen Therapeutics Holdings has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does CARsgen Therapeutics Holdings' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CARsgen Therapeutics Holdings ranks #118 out of 638 companies for Days Inventory. This places CARsgen Therapeutics Holdings in the top 19% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.20. CARsgen Therapeutics Holdings' value of 68.26 is 62.7% below this benchmark. Historically, CARsgen Therapeutics Holdings' own Days Inventory has ranged from 55.22 to 66.43 over the past decade. While the company's 10-year median is 55.81 vs. the industry median of 183.20, CARsgen Therapeutics Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CARsgen Therapeutics Holdings's current Days Inventory of 68.26 is 62.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on CARsgen Therapeutics Holdings and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CARsgen Therapeutics Holdings's current Days Inventory is 68.26, which is 22% above median its own 10-year median of 55.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CARsgen Therapeutics Holdings stock overvalued right now?
CARsgen Therapeutics Holdings (CRTHF) has a current Days Inventory of 68.26. The current Days Inventory is 68.26, which is 22% above median its 10-year median of 55.81 and 62.7% below the Biotechnology industry median of 183.20. CARsgen Therapeutics Holdings' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For CARsgen Therapeutics Holdings (CRTHF), the current Days Inventory is 68.26 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CARsgen Therapeutics Holdings Business Description
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America. During the year, a majority of the Group's revenue was derived from one customer located in the Chinese mainland.
21GF Score
Get the complete analysis for CRTHF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CRTHF has been successfully added to your 
